Vineet Laboratories Ltd

Mon 31/08/2026,15:53:7 | NSE : VINEETLAB

₹38.860.18 (0.47%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 37.35

Previous Close

₹ 38.68

Volume

203649

Mkt Cap ( ₹ Cr)

₹ 74.64

High

₹ 39.29

Low

₹ 37.35

52 Week High

₹ 43.50

52 Week Low

₹ 27.96

Book Value Per Share

₹ 13.05

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Vineet Laboratories Ltd

Your Vote -

Buy

33.33%

Hold

0.00%

Sell

66.67%

33.33%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Vineet Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vineet Laboratories - General Updates

    29 Aug 2026, 7:01PM Vineet Laboratories Limited has informed the Exchange about General Updates

  • Vineet Laboratories - Results-Delay in Financial Results

    29 Aug 2026, 5:53PM Updated Financial Results for the Quarter and Finacial year ended 31st March 2026

  • Vineet Laboratories - Outcome of Board Meeting

    25 Aug 2026, 7:52PM Vineet Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

  • Vineet Laboratories - Outcome of Board Meeting

    25 Aug 2026, 7:36PM Vineet Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.The Board of Directors of the compa

  • Vineet Laboratories - Results-Delay in Financial Results

    25 Aug 2026, 7:29PM The Board of Director of the company in its meeting held on August 25 2026\r\nApproved the Audited Standalone Financial Results for the fourth quarter

  • Vineet Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, August 25, 2026 As Required Under R

    25 Aug 2026, 7:13PM The Board of Directors of the company in its meeting held today i.e., on August 25, 2026 has:\r\nApproved the Audited Standalone Financial Results of

  • Vineet Laboratories - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listi

    20 Aug 2026, 6:24PM Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 ,inter alia, to consider

  • Vineet Laboratories - Monitoring Agency Report

    14 Aug 2026, 7:04PM Please find the attached Monitoring Agency Report issued by CRISIL rating Limited for quarter ended June 30, 2026

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    14 Aug 2026, 7:00PM Please find the attached Monitoring Agency Report issued by CRISIL rating Limited for quarter ended June 30, 2026

  • Vineet Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    1 Aug 2026, 7:00AM As of June 2026, 5.98% is owned by Indian Promoters and 94.02% by Public. <p align=justify> Top five Promoters holding highest number of shares of Vin

  • Vineet Laboratories - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    30 Jul 2026, 11:18PM Vineet Laboratories Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__

  • Vineet Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    30 Jul 2026, 10:34PM Vineet Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Vineet Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    30 Jul 2026, 10:12PM We are hereby submitting the compliance Certificate issued by Venture Capital and Corporate Inveatments Private Limited

  • Vineet Laboratories - Cessation

    21 Jul 2026, 10:27PM Vineet Laboratories Limited has informed the Exchange regarding Cessation of Mr. Gaddam Venkata Ramana (DIN: 00031873) as Managing Director of the c

  • Vineet Laboratories - Change in Director(s)

    21 Jul 2026, 10:20PM Vineet Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Managing Director

    21 Jul 2026, 10:17PM We are hereby informed that Mr. Gaddam Venkata Ramana ( DIN:00031873) has ceased to hold office of Managing Director of Vineet Laboratories with effec

  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    21 Jul 2026, 9:59PM Appointment of Rajesh Kumar Kathulla as an Additional Director (Executive Catagory) of the company with effect from 11th day of June, 2026

  • Vineet Laboratories - General Updates

    16 Jul 2026, 5:02PM Intimation regarding deferment of Board Meeting.

  • Vineet Laboratories - Intimation Of Diferment Of Board Meeting

    16 Jul 2026, 12:53PM Intimation regarding diferment of Board Meeting

  • Vineet Laboratories - General Updates

    11 Jul 2026, 8:21PM Vineet Laboratories Limited has informed the Exchange about General Updates

  • Vineet Laboratories - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listi

    11 Jul 2026, 7:30PM Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026 ,inter alia, to consider

  • Vineet Laboratories - Disclosure under SEBI Takeover Regulations

    24 Jun 2026, 11:53AM A SRINIVASA RAJU has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Vineet Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 54.6947 79.0239 64.7723 59.7318 39.0878
Liabilities 54.6947 79.0239 64.7723 59.7318 39.0878
Equity 9.219 9.219 9.219 9.219 9.219
Gross Profit -16.2831 7.2002 7.6597 13.2445 8.1456
Net Profit -20.191 1.0271 1.2525 6.6386 1.7802
Cash From Operating Activities 11.4909 -11.4272 -9.6162 0 -8.7123
NPM(%) -26.92 0.68 0.58 3.47 0.73
Revenue 74.995 150.5913 212.2933 191.1723 243.4789
Expenses 91.2781 143.3911 204.6336 177.9278 235.3333
ROE(%) -80.57 4.09 4.99 26.49 7.1

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
19 Sep 2022 1 10 0 58.75

Peers

Other companies within the same industry or sector that are comparable to Vineet Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 897.90 -0.08 22.71 22.47 -26.19 0.56
Lotus Eye Hospital and Institute Ltd 109.08 -1.30 1558.29 81.90 0.39 0.00
Vaishali Pharma Ltd 8.06 -3.01 25.19 513.76 15.42 0.00
Astec Lifesciences Ltd 560.70 -3.57 0.00 87.75 -363.14 0.00

Company Info

Vineet Laboratories Limited ("Resulting Company") is a public limited company incorporated under the provisions of the Companies Act, 2013, on 10th day of November, 2016. The Corporate Identity Number of Resulting Company is U24304TG2016PLC112888. The objects of the Resulting Company enable it to carry on the business of manufacturing of bulk drugs intermediates and API Intermediates. The PAN of the Company is AAFCV6694P. Vineet Laboratories Limited is also been certified as an ISO 14001: 2015 Company by the internationally recognised Quality Management Certification Body, in pursuance of its focus towards Environmental Management System.

Vineet Laboratories Limited ("Resulting Company") is a public limited company incorporated under the provisions of the Companies Act, 2013, on 10th day of November, 2016. The Corporate Identity Number of Resulting Company is U24304TG2016PLC112888. The objects of the Resulting Company enable it to carry on the business of manufacturing of bulk drugs intermediates and API Intermediates. The PAN of the Company is AAFCV6694P. Vineet Laboratories Limited is also been certified as an ISO 14001: 2015 Company by the internationally recognised Quality Management Certification Body, in pursuance of its focus towards Environmental Management System.

Parent Organisation

Vineet Laboratories Ltd.

Founded

10/11/2016

Managing Director

Mr.Gaddam Venkata Ramana

NSE Symbol

VINEETLABEQ

FAQ